Simulations Plus

Simulations Plus Operating Expenses

The Total Operating Expenses of Simulations Plus (SLP) as of Oct 13, 2026 is 27.83 M USD. In the previous year, Total Operating Expenses was 28.11 M USD — a change of -1.00% (lower).

Operating Expenses

27.83 MUSD

YoY

-1.00%

Last updated:

Total Operating Expenses of Simulations Plus is 2025 27.83 M USD. Total Operating Expenses of Simulations Plus was 2024 28.11 M USD. It decreases by -1.00% lower compared to the previous year.

The Simulations Plus Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
11.37 M USD
Jan 1, 2019
14.30 M USD
Jan 1, 2020
19.34 M USD
Jan 1, 2021
24.61 M USD
Jan 1, 2022
23.29 M USD
Jan 1, 2023
39.22 M USD
Jan 1, 2024
28.11 M USD
Jan 1, 2025
27.83 M USD
The Simulations Plus Operating Expenses history
YEAROperating ExpensesYoY
27.83 MUSD-1.00%
28.11 MUSD-28.34%
39.22 MUSD+68.38%
23.29 MUSD-5.36%
24.61 MUSD+27.30%
19.34 MUSD+35.25%
14.30 MUSD+25.68%
11.37 MUSD+18.91%
9.57 MUSD+19.47%
8.01 MUSD-1.20%
8.10 MUSD+50.28%
5.39 MUSD—
Access this data via the Eulerpool API

Simulations Plus Stock analysis

What does Simulations Plus do? Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Simulations Plus stock

Total Operating Expenses of Simulations Plus is 27.83 M USD in 2025.

Total Operating Expenses of Simulations Plus changed from 28.11 M USD to 27.83 M USD, representing a -1.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Simulations Plus since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Simulations Plus historically and in real time.

Access this data via the Eulerpool API

Income Statement — Simulations Plus

All Key Metrics — Simulations Plus